Forum Topic News
  • Conversation: CAR T-Cell Treatment

    • December 4, 2018 10:48 AM GMT
    • CAR T-Cell Treatment

      Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types of aggressive blood cancers, in whom treatment options have been woefully limited. Five studies being presented today at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition spotlight the long-term effectiveness of these therapies in some patients, analyze how combination therapies might affect treatment responses, and examine if transplantation following CAR T-cell therapy affects remission rate.
      CAR T-cell therapies are designed by harvesting a patient's own T cells (the immune system's primary cancer-killing cells), reengineering them to target specific proteins on the surface of cancer cells, and reintroducing the modified T cells back into the patient's immune system.
      Read more: https://prn.to/2KUlw6q

Add Reputation

Do you want to add reputation for this member by this post?

or cancel
‚Äč